Marizyme appoints two new board members

Marizyme appoints two new board members

FORT COLLINS -- Marizyme, Inc., a publicly traded (OTC:MRZM) company focusing on acquiring late-stage drug assets for use in the acute care space for development and commercialization, today... Read More

Monday December 17, 2018 0 comments Tags: Fort Collins, Marizyme, James Sapirstein, Terry Brostowin, Michael Handley